Sales decline 30.38% to Rs 2.20 crore
Net Loss of Norris Medicines reported to Rs 0.79 crore in the quarter ended September 2021 as against net loss of Rs 1.29 crore during the previous quarter ended September 2020. Sales declined 30.38% to Rs 2.20 crore in the quarter ended September 2021 as against Rs 3.16 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales2.203.16 -30 OPM %-5.91-26.27 -PBDT-0.63-1.11 43 PBT-0.79-1.29 39 NP-0.79-1.29 39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content